News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
cancer research

HIPEC With Cisplatin, Mitomycin, and Paclitaxel for Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology

Gastric cancer patients whose disease had spread to the peritoneum received infusions of mitomycin, cisplatin and paclitaxel into the peritoneum in a clinical trial and had 1- and 2-year survival rates of 74% and 58%.

Read Source
DonateMore InfoDonateMore Info
We cannot gather at a gala event this year, but a pandemic cannot stop us from joining together to ensure that the search to find a cure for gastric (stomach) cancer continues.

Join with us to fuel the next wave of progress.

Every contribution moves us closer to a cure.
Please join with us to fuel the next wave of progress. Together, we will defeat stomach cancer.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.